Article Information
History
- October 18, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Lisa M Hobson1,2,*,
- Prof. Richard M Martin2,3,
- Dr. Karl Smith-Byrne3,4,
- Prof. George Davey Smith1,3,
- Prof. Gibran Hemani1,3,
- Dr. Joseph H Gilbody1,2,
- Dr. James Yarmolinsky1,2,5,
- Dr. Sarah ER Bailey6,
- Dr. Lucy J. Goudswaard1,2,* and
- Dr. Philip C Haycock1,*
- 1MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol
- 2Population Health Sciences, Bristol Medical School, University of Bristol
- 3Bristol NIHR Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol
- 4Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford
- 5Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
- 6Department of Health and Community Science, University of Exeter
- ↵*Corresponding Authors Lisa M Hobson, MRC Integrative Epidemiology Unit, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, Lisa.hobson{at}bristol.ac.uk, Lucy J Goudswaard, MRC Integrative Epidemiology Unit, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, lucy.goudswaard{at}bristol.ac.uk, Philip C Haycock, MRC Integrative Epidemiology Unit, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, philip.haycock{at}bristol.ac.uk
Posted October 18, 2024.
A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes
